300016 北陸藥業
按盤價 
10.000 +0.560 (+5.932%)
10.000 +0.560 (+5.932%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.278 | 0.823 | -4.188 | 0.621 | 6.975 |
| 總資產報酬率 ROA (%) | 1.425 | 0.471 | -2.545 | 0.394 | 4.364 |
| 投入資產回報率 ROIC (%) | 1.609 | 0.529 | -2.826 | 0.443 | 4.958 | 邊際利潤分析 |
| 銷售毛利率 (%) | 45.873 | 47.674 | 47.008 | 55.390 | 62.270 |
| 營業利潤率 (%) | 5.250 | -0.061 | -11.276 | -1.734 | 14.789 |
| 息稅前利潤/營業總收入 (%) | 9.232 | 5.198 | -6.388 | 3.554 | 17.415 |
| 淨利潤/營業總收入 (%) | 4.522 | 0.027 | -9.341 | -0.594 | 12.826 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 72.849 | -332.391 | 56.298 | 165.688 | 71.042 |
| 價值變動淨收益/利潤總額(%) | 26.641 | 585.450 | 7.873 | -139.154 | 22.088 |
| 營業外收支淨額/利潤總額(%) | -1.852 | 23.990 | 0.708 | 10.020 | -3.938 | 償債能力分析 |
| 流動比率 (X) | 2.221 | 2.573 | 3.332 | 3.892 | 4.574 |
| 速動比率 (X) | 1.611 | 1.777 | 2.650 | 2.979 | 3.698 |
| 資產負債率 (%) | 26.470 | 38.557 | 36.643 | 31.766 | 28.173 |
| 帶息債務/全部投入資本 (%) | 19.467 | 32.972 | 31.748 | 27.091 | 24.883 |
| 股東權益/帶息債務 (%) | 396.525 | 192.592 | 204.874 | 258.021 | 292.957 |
| 股東權益/負債合計 (%) | 259.271 | 145.255 | 159.771 | 198.395 | 226.957 |
| 利息保障倍數 (X) | 2.264 | 0.985 | -1.285 | 0.648 | 5.466 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 59.399 | 65.027 | 58.856 | 56.390 | 63.644 |
| 存貨周轉天數 (天) | 208.588 | 212.280 | 198.714 | 277.242 | 203.681 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 13/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
